#	Pagina
attuale pagina	/open-h2020/projects/193288/index.html

Opendata, web and dolomites

I-MOVE-plus SIGNED

I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

I-MOVE-plus project word cloud

Explore the words cloud of the I-MOVE-plus project. It provides you a very rough idea of what is the project "I-MOVE-plus" about.

pneumococcal pneumococcus health time direct international practices ve schedules designs outcomes alone population confirmed serotypes universities serotype decision validated vi effect benefit marketing union strain public shared pilot occurrence laboratory post vaccines care measuring hospitals vaccination elderly boosters repeated protection brands guide influenza questions performances sme achievements interaction country strategies institutes subtypes countries vaccinations sizes doses networks vaccine committees share indirect types disease whatever primary understand indicators expertise sustainable effectiveness platform replacement disseminate clinical move basis sharing

Project "I-MOVE-plus" data sheet

The following table provides information about the project.

Coordinator	EPICONCEPT Organization address address: RUE DE CHARENTON 47 city: PARIS postcode: 75012 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	France [FR]
Project website	https://sites.google.com/a/epiconcept.fr/imoveplus/
Total cost	7˙520˙005 €
EC max contribution	7˙482˙728 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-PHC-2014-two-stage
Funding Scheme	RIA
Starting year	2015
Duration (year-month-day)	from 2015-05-01 to 2018-10-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	EPICONCEPT EPICONCEPT Organization address address: RUE DE CHARENTON 47 city: PARIS postcode: 75012 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	coordinator	1˙647˙873.00
2	Department of Health Department of Health Organization address address: Quarry House, Quarry Hill city: Leeds postcode: LS2 7UE website: www.dh.gov.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (Leeds)	participant	587˙308.00
3	RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU Organization address address: Antonie Van Leeuwenhoeklaan 9 city: BILTHOVEN postcode: 3721 MA website: www.rivm.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (BILTHOVEN)	participant	519˙507.00
4	STATENS SERUM INSTITUT STATENS SERUM INSTITUT Organization address address: ARTILLERIVEJ 5 city: KOBENHAVN S postcode: 2300 website: www.ssi.dk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (KOBENHAVN S)	participant	510˙490.00
5	TERVEYDEN JA HYVINVOINNIN LAITOS TERVEYDEN JA HYVINVOINNIN LAITOS Organization address address: MANNERHEIMINTIE 166 city: HELSINKI postcode: 271 website: www.thl.fi contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FI (HELSINKI)	participant	448˙650.00
6	ISTITUTO SUPERIORE DI SANITA ISTITUTO SUPERIORE DI SANITA Organization address address: Viale Regina Elena 299 city: ROMA postcode: 161 website: http://www.iss.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (ROMA)	participant	392˙500.00
7	INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE Organization address address: AVENIDA PADRE CRUZ city: LISBOA postcode: 1600 560 website: http://www.insa.pt contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	PT (LISBOA)	participant	350˙158.00
8	HEALTH SERVICE EXECUTIVE HSE HEALTH SERVICE EXECUTIVE HSE Organization address address: LIMETREE AVENUE 2ND FLO OAK HOUSE city: NAAS postcode: n.a. website: www.hse.ie contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IE (NAAS)	participant	325˙015.00
9	INSTITUTO DE SALUD CARLOS III INSTITUTO DE SALUD CARLOS III Organization address address: MONFORTE DE LEMOS 5 city: MADRID postcode: 28029 website: http://www.isciii.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	participant	324˙588.00
10	INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE MEDICO-MILITARA CANTACUZINO INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE MEDICO-MILITARA CANTACUZINO Organization address address: SPLAIUL INDEPENDENTEI 103 SECTOR 5 city: BUCURESTI postcode: 50096 website: www.cantacuzino.ro contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	RO (BUCURESTI)	participant	248˙625.00
11	NARODOWY INSTYTUT ZDROWIA PUBLICZNEGO-PANSTWOWY ZAKLAD HIGIENY NARODOWY INSTYTUT ZDROWIA PUBLICZNEGO-PANSTWOWY ZAKLAD HIGIENY Organization address address: CHOCIMSKA 24 city: WARSZAWA postcode: 791 website: www.pzh.gov.pl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	PL (WARSZAWA)	participant	242˙500.00
12	ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA Organization address address: CL LEYRE 15 city: PAMPLONA postcode: 31003 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (PAMPLONA)	participant	236˙250.00
13	HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO Organization address address: ROCKEFELLEROVA 7 city: ZAGREB postcode: 10000 website: www.hzjz.hr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HR (ZAGREB)	participant	217˙500.00
14	ROBERT KOCH-INSTITUT ROBERT KOCH-INSTITUT Organization address address: Nordufer 20 city: Berlin postcode: 13353 website: www.rki.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (Berlin)	participant	182˙515.00
15	NHS NATIONAL SERVICES SCOTLAND NHS NATIONAL SERVICES SCOTLAND Organization address address: SOUTH GYLE CRESCENT 1 city: EDINBURGH postcode: EH12 9EB website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (EDINBURGH)	participant	182˙335.00
16	STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG Organization address address: OTTERSTRAAT 118-124 city: UTRECHT postcode: 3500 BN website: www.nivel.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (UTRECHT)	participant	173˙007.00
17	THE ROYAL COLLEGE OF GENERAL PRACTITIONERS THE ROYAL COLLEGE OF GENERAL PRACTITIONERS Organization address address: PRINCES GATE - HYDE PARK 14 city: LONDON postcode: SW7 1PU website: http://www.rcgp.org.uk/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	162˙506.00
18	SORBONNE UNIVERSITE SORBONNE UNIVERSITE Organization address address: 21 RUE DE L'ECOLE DE MEDECINE city: PARIS postcode: 75006 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	142˙500.00
19	ORSZAGOS TISZTIFOORVOSI HIVATAL ORSZAGOS TISZTIFOORVOSI HIVATAL Organization address address: ALBERT FLORIAN UT 2-6. city: BUDAPEST postcode: 1097 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (BUDAPEST)	participant	139˙841.00
20	FOLKEHELSEINSTITUTTET FOLKEHELSEINSTITUTTET Organization address address: LOVISENBERGGATA 8 city: OSLO postcode: 456 website: www.fhi.no contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (OSLO)	participant	120˙343.00
21	ASSISTANCE PUBLIQUE HOPITAUX DE PARIS ASSISTANCE PUBLIQUE HOPITAUX DE PARIS Organization address address: 3 AVENUE VICTORIA city: PARIS postcode: 75000 website: http://www.aphp.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	90˙000.00
22	HOSPICES CIVILS DE LYON HOSPICES CIVILS DE LYON Organization address address: QUAI DES CELESTINS 3 city: LYON postcode: 69002 website: www.chu-lyon.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (LYON)	participant	80˙722.00
23	CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER Organization address address: AVENUE DU DOYEN GASTON GIRAUD 191 city: MONTPELLIER postcode: 34000 website: www.chu-montpellier.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (MONTPELLIER)	participant	60˙000.00
24	LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS Organization address address: A MICKEVICIAUS GATVE 9 city: KAUNAS postcode: 44307 website: www.lsmuni.lt contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	LT (KAUNAS)	participant	50˙000.00
25	CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES Organization address address: RUE HENRI LE GUILLOUX -HOPITAL 2 city: RENNES CEDEX 9 postcode: 35033 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (RENNES CEDEX 9)	participant	25˙000.00
26	THE UNIVERSITY OF EDINBURGH THE UNIVERSITY OF EDINBURGH Organization address address: OLD COLLEGE, SOUTH BRIDGE city: EDINBURGH postcode: EH8 9YL website: www.ed.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (EDINBURGH)	participant	18˙931.00
27	EMBERI EROFORRASOK MINISZTERIUMA EMBERI EROFORRASOK MINISZTERIUMA Organization address address: AKADEMIA UTCA. 3 city: BUDAPEST postcode: 1054 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (BUDAPEST)	participant	4˙058.00
28	AGENCE NATIONALE DE SANTE PUBLIQUE AGENCE NATIONALE DE SANTE PUBLIQUE Organization address address: 12 RUE DU VAL D'OSNE city: SAINT MAURICE postcode: 94415 website: www.santepubliquefrance.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (SAINT MAURICE)	participant	0.00
29	INSTITUT DE VEILLE SANITAIRE INSTITUT DE VEILLE SANITAIRE Organization address address: RUE DU VAL D OSNE 12 city: SAINT MAURICE CEDEX postcode: 94415 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (SAINT MAURICE CEDEX)	participant	0.00
30	UNIVERSITE DE CORSE PASCAL PAOLI UNIVERSITE DE CORSE PASCAL PAOLI Organization address address: AVENUE JEAN NICOLI 7 city: CORTE postcode: 20250 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (CORTE)	participant	0.00
31	UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6 UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6 Organization address address: Place Jussieu 4 city: PARIS postcode: 75252 website: www.upmc.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	0.00

Map

Project objective

The I-MOVE Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination strategies a in the elderly population in Europe. The goal is to develop a sustainable platform of primary care practices, hospitals and laboratory networks that share validated methods to evaluate post marketing vaccine performances. The objectives are to identify, pilot test, and disseminate in EU the best study designs to measure, on a real time basis, VE (direct effect) and the VI of vaccination programmes (indirect and overall effect) against laboratory confirmed cases of influenza (types/subtypes) and pneumococcal disease (serotypes), and clinical outcomes. Cost effectiveness analysis will be conducted.

Results will allow to understand factors affecting specific VE, the duration of protection of influenza and pneumococcal vaccines, the interaction between vaccines, the role of repeated vaccinations, the occurrence of serotype replacement (pneumococcus); identify vaccine types and brands with low VE; guide the decision of the WHO committees on vaccine strain selection (influenza); provide robust benefit indicators (VE and VI) and cost benefit and effectiveness results; guide vaccination strategies (schedules, doses, boosters). This EU member state collaboration will respond to questions that require studies based on large sample sizes and sharing of expertise that cannot be achieved by one country alone. It will allow the best methods to be used and results to benefit to all EU countries whatever their current public health achievements. Results will be shared with international partners.

Deliverables

List of deliverables.
Third End of season, pooled influenza vaccine effectiveness estimates report.	Documents, reports	2020-02-20 17:22:44
Scientific communication	Documents, reports	2020-02-20 17:22:44
Submission of article summarising the I-MOVE+ experience in evaluating the influenza vaccines, results and perspective for the future.	Documents, reports	2020-02-20 17:22:44
Third Report I-MOVE+ ST/Scientific Meetings	Documents, reports	2020-02-20 17:22:45
Scientific manuscript WP4	Documents, reports	2020-02-20 17:22:44
Scientific Manuscript WP5	Documents, reports	2020-02-20 17:22:45
Third Study sites protocols and clearance from Ethical Committee to measure influenza vaccine effectiveness.	Documents, reports	2020-02-20 17:22:44
Training material available.	Documents, reports	2020-02-20 17:22:44
Report on influenza vaccine effectiveness and role of influenza on IPD and/or CAP incidence	Documents, reports	2020-02-20 17:22:44
Third Scientific communication: one article submitted or results from I-MOVE+ influenza vaccines presented in an International Scientific Conference.	Documents, reports	2020-02-20 17:22:44
One manuscript submitted for publication and/or abstracts for at least one conference.	Documents, reports	2020-02-20 17:22:44
First End of season, pooled influenza vaccine effectiveness estimates report.	Documents, reports	2020-02-20 17:22:41
Report with description of influenza and pneumococcal outcomes in each database.	Documents, reports	2020-02-20 17:22:42
First Scientific communication: one article submitted or results from I-MOVE+ influenza vaccines presented in an International Scientific Conference.	Documents, reports	2020-02-20 17:22:41
Second Scientific communication: one article submitted or results from I-MOVE+ influenza vaccines presented in an International Scientific Conference.	Documents, reports	2020-02-20 17:22:41
Generic protocols for effectiveness and impact studies of pneumococcal vaccines	Documents, reports	2020-02-20 17:22:41
First Study sites protocols and clearance from Ethical Committee to measure influenza vaccine effectiveness.	Documents, reports	2020-02-20 17:22:42
Second Study sites protocols and clearance from Ethical Committee to measure influenza vaccine effectiveness.	Documents, reports	2020-02-20 17:22:42
First Report I-Move+ ST/Scientific Meetings	Documents, reports	2020-02-20 17:22:41
Second. Study sites protocols and clearance from Ethical Committee to measure influenza vaccine effectiveness.	Documents, reports	2020-02-20 17:22:41
Written report including a generic cost-effectiveness model	Documents, reports	2020-02-20 17:22:44
Third. Study sites protocols and clearance from Ethical Committee to measure influenza vaccine effectiveness.	Documents, reports	2020-02-20 17:22:42
Generic protocols to measure influenza vaccine effectiveness at primary care and hospital level, using a test-negative design and screening method.	Documents, reports	2020-02-20 17:22:43
I-MOVE+ website with different access level and tools for internal collaboration, communication	Websites, patent fillings, videos etc.	2020-02-20 17:22:41
Second Study sites protocols to measure influenza vaccine impact in season.	Documents, reports	2020-02-20 17:22:41
Third Study sites protocols to measure influenza vaccine impact in season.	Documents, reports	2020-02-20 17:22:41
Second Report I-MOVE+ ST/Scientific Meetings	Documents, reports	2020-02-20 17:22:41
Second End of season, pooled influenza vaccine effectiveness estimates report.	Documents, reports	2020-02-20 17:22:41
First season Study sites protocols and clearance from Ethical Committee to measure influenza vaccine effectiveness.	Documents, reports	2020-02-20 17:22:40
First season Study sites protocols to measure influenza vaccine impact in season.	Documents, reports	2020-02-20 17:22:40
Generic protocol to measure impact of the seasonal influenza vaccine	Documents, reports	2020-02-20 17:22:40

Take a look to the deliverables list in detail: detailed list of I-MOVE-plus deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2016	Hanne Dorthe Emborg, Tyra Grove Krause, Lene Nielsen, Marianne Kragh Thomsen, Claus Bohn Christiansen, Marianne Nielsine Skov, Xiaohui Chen Nielsen, Lenette Sandborg Weinreich, Thea KÃ¸lsen Fischer, Jesper RÃ¸nn, Ramona Trebbien Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 â€“ a rapid epidemiological and virological assessment published pages: , ISSN: 1025-496X, DOI: 10.2807/1560-7917.ES.2016.21.14.30189	Eurosurveillance 21/14	2020-02-20
2017	Dominic Thorrington, Edwin van Leeuwen, Mary Ramsay, Richard Pebody, Marc Baguelin Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England published pages: , ISSN: 1741-7015, DOI: 10.1186/s12916-017-0932-3	BMC Medicine 15/1	2020-02-20
2017	Maria-Pia Hergens, Ulrike Baum, Mia Brytting, Niina Ikonen, Anu Haveri, Ã…sa Wiman, Hanna Nohynek, Ã…ke Ã–rtqvist Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017 published pages: , ISSN: 1025-496X, DOI: 10.2807/1560-7917.ES.2017.22.8.30469	Eurosurveillance 22/8	2020-02-20
2017	Jim Mc Menamin Success of vaccination programmes is based on citizenÂ´s trus in safety of vaccines published pages: , ISSN: , DOI:	The Parliament Magazine	2020-02-20
2017	Marc Rondy, Odile Launay, Jesus Castilla, Simona Costanzo, Joan Puig-BarberÃ , Giedre Gefenaite, Amparo Larrauri, Caterina Rizzo, Daniela Pitigoi, Ritva K. SyrjÃ¤nen, Ausenda Machado, Sanja KureÄiÄ‡ FilipoviÄ‡, Judit Krisztina HorvÃ¡th, Iwona Paradowska-Stankiewicz, Sierk Marbus, Alain Moren Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza published pages: 4298-4306, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2017.06.088	Vaccine 35/34	2020-02-20
2017	IvÃ¡n MartÃnez-Baz, Itziar Casado, Ana NavascuÃ©s, Jorge DÃaz-GonzÃ¡lez, Aitziber Aguinaga, Laura Barrado, Josu Delfrade, Carmen Ezpeleta, JesÃºs Castilla Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus published pages: , ISSN: 0022-1899, DOI: 10.1093/infdis/jix055	The Journal of Infectious Diseases	2020-02-20
2017	A.M. Vilcu, C. Souty, V. Enouf, L. Capai, C. Turbelin, S. Masse, S. Behillil, M. Valette, C. Guerrisi, L. Rossignol, T. Blanchon, B. Lina, T. Hanslik, A. Falchi Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method published pages: , ISSN: 1198-743X, DOI: 10.1016/j.cmi.2017.09.003	Clinical Microbiology and Infection	2020-02-20
2017	Alin Gherasim, IvÃ¡n MartÃnez-Baz, JesÃºs Castilla, Francisco Pozo, Amparo Larrauri Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain published pages: e0179160, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0179160	PLOS ONE 12/6	2020-02-20
2017	Marc Rondy, Amparo Larrauri, Itziar Casado, Valeria Alfonsi, Daniela Pitigoi, Odile Launay, Ritva K SyrjÃ¤nen, Giedre Gefenaite, Ausenda Machado, Vesna ViÅ¡ekruna VuÄina, Judith Krisztina HorvÃ¡th, Iwona Paradowska-Stankiewicz, Sierk D Marbus, Alin Gherasim, Jorge Alberto DÃaz-GonzÃ¡lez, Caterina Rizzo, Alina E Ivanciuc, Florence Galtier, Niina Ikonen, Aukse Mickiene, Veronica Gomez, Sanja KureÄiÄ‡ FilipoviÄ‡, AnnamÃ¡ria Ferenczi, Monika R Korcinska, Rianne van Gageldonk-Lafeber, Marta Valenciano 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project published pages: , ISSN: 1025-496X, DOI: 10.2807/1560-7917.ES.2017.22.30.30580	Eurosurveillance 22/30	2020-02-20
2017	CÃ©cile Souty, Ana-Maria Vilcu, Lisandru Capai, Sylvie van der Werf, Martine Valette, Thierry Blanchon, Bruno Lina, Sylvie Behillil, Thomas Hanslik, Alessandra Falchi Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France published pages: 1-4, ISSN: 1386-6532, DOI: 10.1016/j.jcv.2017.08.002	Journal of Clinical Virology 95	2020-02-20
2016	GÃ³mez, VerÃ³nica; Guiomar, Raquel; Rodrigues, Ana Paula; Pechirra, Pedro; Conde, PatrÃcia; CristÃ³vÃ£o, Paula; Costa, InÃªs; Nunes, Baltazar; Machado, Ausenda Influenza vaccine effectiveness in Portugal: season 2015/2016 report published pages: , ISSN: , DOI:	2	2020-02-20
2016	Richard Pebody, Fiona Warburton, Joanna Ellis, Nick Andrews, Alison Potts, Simon Cottrell, Jillian Johnston, Arlene Reynolds, Rory Gunson, Catherine Thompson, Monica Galiano, Chris Robertson, David Mullett, Naomh Gallagher, Mary Sinnathamby, Ivelina Yonova, Catherine Moore, Jim McMenamin, Simon de Lusignan, Maria Zambon Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results published pages: , ISSN: 1025-496X, DOI: 10.2807/1560-7917.ES.2016.21.13.30179	Eurosurveillance 21/13	2020-02-20
2016	Rodrigues, Ana Paula; Pechirra, Pedro; Guiomar, Raquel; Conde, PatrÃcia; Gomez, VerÃ³nica; Nunes, Baltazar; Machado, Ausenda Virological data integration on influenza vaccine effectiveness, Portugal 2015/16 published pages: , ISSN: , DOI:	1	2020-02-20
2017	Esther Kissling, Marc Rondy Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe published pages: , ISSN: 1025-496X, DOI: 10.2807/1560-7917.ES.2017.22.7.30464	Eurosurveillance 22/7	2020-02-20
2016	Jim McMenamin Vaccine performance needs careful and independent evaluation published pages: , ISSN: , DOI:	The Parliament Magazine Issue 432/18 April 2016	2020-02-20
2017	JesÃºs Castilla, Ana NavascuÃ©s, Itziar Casado, Jorge DÃaz-GonzÃ¡lez, Alejandra PÃ©rez-GarcÃa, Leticia Fernandino, IvÃ¡n MartÃnez-Baz, Aitziber Aguinaga, Francisco Pozo, Carmen Ezpeleta Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis published pages: , ISSN: 1025-496X, DOI: 10.2807/1560-7917.ES.2017.22.7.30465	Eurosurveillance 22/7	2020-02-20
2018	Dominic Thorrington, Leo van Rossum, Mirjam Knol, Hester de Melker, Hans RÃ¼mke, Eelko Hak, Albert Jan van Hoek Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands published pages: e0192640, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0192640	PLOS ONE 13/2	2020-02-20
2019	Irina Kislaya, Ana Paula Rodrigues, Mafalda Sousa-Uva, VerÃ³nica GÃ³mez, Paulo GonÃ§alves, Filipe Froes, Baltazar Nunes Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly published pages: e0209428, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0209428	PLOS ONE 14/1	2020-02-20
2017	Marc Rondy, Alin Gherasim, Itziar Casado, Odile Launay, Caterina Rizzo, Daniela Pitigoi, Aukse Mickiene, Sierk D Marbus, Ausenda Machado, Ritva K SyrjÃ¤nen, Iva Pem-Novose, Judith Krisztina HorvÃ¡th, Amparo Larrauri, JesÃºs Castilla, Philippe Vanhems, Valeria Alfonsi, Alina E Ivanciuc, Monika Kuliese, Rianne van Gageldonk-Lafeber, Veronica Gomez, Niina Ikonen, Zvjezdana Lovric, AnnamÃ¡ria Ferenczi, Alain Moren Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season published pages: , ISSN: 1560-7917, DOI: 10.2807/1560-7917.ES.2017.22.41.17-00645	Eurosurveillance 22/41	2020-02-20
2018	Marc Rondy, Esther Kissling, Hanne-Dorthe Emborg, Alin Gherasim, Richard Pebody, Ramona Trebbien, Francisco Pozo, Amparo Larrauri, Jim McMenamin, Marta Valenciano Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies published pages: , ISSN: 1560-7917, DOI: 10.2807/1560-7917.ES.2018.23.9.18-00086	Eurosurveillance 23/9	2020-02-20
2018	JesÃºs Castilla, Ana NavascuÃ©s, Itziar Casado, Alejandra PÃ©rez-GarcÃa, Aitziber Aguinaga, Guillermo Ezpeleta, Francisco Pozo, Carmen Ezpeleta, IvÃ¡n MartÃnez-Baz Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 published pages: , ISSN: 1560-7917, DOI: 10.2807/1560-7917.es.2018.23.7.18-00057	Eurosurveillance 23/7	2020-02-20
2018	Itziar Casado, Ãngela DomÃnguez, Diana Toledo, Judith Chamorro, Jenaro Astray, Mikel Egurrola, MarÃa Amelia FernÃ¡ndez-Sierra, Vicente MartÃn, MarÃa Morales-SuÃ¡rez-Varela, Pere Godoy, JesÃºs Castilla Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre caseâ€“control study published pages: E3-E12, ISSN: 0820-3946, DOI: 10.1503/cmaj.170910	Canadian Medical Association Journal 190/1	2020-02-20
2018	Germaine Hanquet, Pavla Krizova, Palle Valentiner-Branth, Shamez N Ladhani, J Pekka Nuorti, Agnes Lepoutre, Jolita Mereckiene, Mirjam Knol, Brita A Winje, Pilar Ciruela, Maria Ordobas, Marcela Guevara, Eisin McDonald, Eva Morfeldt, Jana Kozakova, Hans-Christian Slotved, Norman K Fry, Hanna Rinta-Kokko, Emmanuelle Varon, Mary Corcoran, Arie van der Ende, Didrik F Vestrheim, Carmen Munoz-Almagro, Pello Latasa, Jesus Castilla, Andrew Smith, Birgitta Henriques-Normark, Robert Whittaker, Lucia Pastore Celentano, Camelia Savulescu Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination published pages: thoraxjnl-2018-2, ISSN: 0040-6376, DOI: 10.1136/thoraxjnl-2018-211767	Thorax	2020-02-20
2018	Richard G Pebody, Mary A Sinnathamby, Fiona Warburton, Nick Andrews, Nicola L Boddington, Hongxin Zhao, Ivelina Yonova, Joanna Ellis, Elise Tessier, Matthew Donati, Alex J Elliot, Helen E Hughes, Sameera Pathirannehelage, Rachel Byford, Gillian E Smith, Simon de Lusignan, Maria Zambon Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16 published pages: , ISSN: 1560-7917, DOI: 10.2807/1560-7917.es.2018.23.25.1700496	Eurosurveillance 23/25	2020-02-20
2018	Adam Meijer, Corien M Swaan, Martin Voerknecht, Edin Jusic, Sharon van den Brink, Lisa A Wijsman, Bettie CG Voordouw, GÃ© A Donker, Jacqueline Sleven, Wendelien W Dorigo-Zetsma, Sanela Svraka, Michiel van Boven, Manon R Haverkate, Aura Timen, Jaap T van Dissel, Marion PG Koopmans, Theo M Bestebroer, Ron AM Fouchier Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018 published pages: , ISSN: 1560-7917, DOI: 10.2807/1560-7917.es.2018.23.15.18-00160	Eurosurveillance 23/15	2020-02-20

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "I-MOVE-PLUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "I-MOVE-PLUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial